This inventor holds 3 USPTO granted patents. Top assignees: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, Spofa United Pharmaceutical Works. Active years: 1980-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 16 
1 out of 8 Years Active: 1980-1984
Title: Karel Sindelar: Innovator in Pharmaceutical Chemistry
Introduction
Karel Sindelar is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on the development of novel compounds with potential therapeutic applications.
Latest Patents
Sindelar's latest patents include innovative techniques for the preparation of tricyclic compounds. One patent describes a method for creating a variety of basic derivatives of linearly condensed tricyclic systems, which consist of two external benzene nuclei and a 7-membered central ring containing two chalcogen atoms as heteroatoms. This work has led to the synthesis of derivatives such as 11H-dibenzo(b,e)-1,4-dioxepin and 11H-dibenzo(b,f)-1,4-dithiepin, among others. Another significant patent involves the preparation of 3-fluoro-10-piperazino-8-substituted 10,11-dihydrodibenzo-(b,f) thiepins, which exhibit psychotropic activity and low toxicity, making them valuable as neuroliptics.
Career Highlights
Throughout his career, Karel Sindelar has worked with several prominent companies in the pharmaceutical industry. He has been associated with Spofa, a well-known pharmaceutical manufacturer, as well as Spojene Podniky Pro Zdravotnickou Vyrobu and Spofa United Pharmaceutical Works. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Sindelar has collaborated with notable colleagues in his field, including Miroslav Protiva and Jirina Metysova. These partnerships have fostered a collaborative environment that has enhanced the research and development of new pharmaceutical compounds.
Conclusion
Karel Sindelar's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile